ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 18 filers reported holding ADMA BIOLOGICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31,870 | -54.6% | 8,902 | -53.2% | 0.00% | -50.0% |
| Q2 2023 | $70,232 | +109637.5% | 19,033 | -2.6% | 0.00% | 0.0% |
| Q1 2023 | $64 | +88.2% | 19,535 | +121.4% | 0.00% | +100.0% |
| Q4 2022 | $34 | -99.9% | 8,823 | -62.3% | 0.00% | 0.0% |
| Q3 2022 | $57,000 | -19.7% | 23,397 | -35.1% | 0.00% | -50.0% |
| Q2 2022 | $71,000 | +115.2% | 36,033 | +99.5% | 0.00% | – |
| Q1 2022 | $33,000 | +266.7% | 18,062 | +175.1% | 0.00% | – |
| Q4 2021 | $9,000 | +800.0% | 6,566 | +1131.9% | 0.00% | – |
| Q2 2021 | $1,000 | -97.8% | 533 | -97.9% | 0.00% | -100.0% |
| Q1 2021 | $46,000 | +31.4% | 25,920 | +40.9% | 0.00% | 0.0% |
| Q4 2020 | $35,000 | -79.0% | 18,393 | -73.7% | 0.00% | -50.0% |
| Q3 2020 | $167,000 | +288.4% | 69,848 | +380.4% | 0.00% | 0.0% |
| Q2 2020 | $43,000 | +26.5% | 14,540 | +70.9% | 0.00% | -33.3% |
| Q4 2019 | $34,000 | +6.2% | 8,506 | +15.8% | 0.00% | +50.0% |
| Q3 2019 | $32,000 | -38.5% | 7,346 | -45.0% | 0.00% | -50.0% |
| Q2 2019 | $52,000 | – | 13,368 | +13268.0% | 0.00% | – |
| Q1 2019 | $0 | -100.0% | 100 | -97.6% | 0.00% | -100.0% |
| Q4 2018 | $10,000 | – | 4,117 | +16368.0% | 0.00% | – |
| Q3 2018 | $0 | -100.0% | 25 | -99.8% | 0.00% | -100.0% |
| Q3 2017 | $36,000 | +800.0% | 11,673 | +923.0% | 0.00% | – |
| Q2 2017 | $4,000 | 0.0% | 1,141 | +49.0% | 0.00% | – |
| Q1 2017 | $4,000 | 0.0% | 766 | -2.4% | 0.00% | – |
| Q4 2016 | $4,000 | -33.3% | 785 | -0.8% | 0.00% | -100.0% |
| Q3 2016 | $6,000 | -33.3% | 791 | -43.6% | 0.00% | 0.0% |
| Q2 2016 | $9,000 | -79.5% | 1,402 | -74.3% | 0.00% | -85.7% |
| Q1 2016 | $44,000 | +1000.0% | 5,456 | +1157.1% | 0.01% | +600.0% |
| Q4 2015 | $4,000 | -33.3% | 434 | -29.9% | 0.00% | 0.0% |
| Q3 2015 | $6,000 | +20.0% | 619 | +23.1% | 0.00% | – |
| Q2 2015 | $5,000 | -50.0% | 503 | -50.0% | 0.00% | -100.0% |
| Q1 2015 | $10,000 | +400.0% | 1,007 | +403.5% | 0.00% | – |
| Q4 2014 | $2,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Velan Capital Investment Management LP | 4,000,000 | $15,520,000 | 13.71% |
| Stonepine Capital Management, LLC | 6,940,000 | $26,927,200 | 11.33% |
| Caligan Partners LP | 2,676,093 | $10,383,241 | 8.64% |
| Altium Capital Management LP | 2,870,000 | $11,135,600 | 5.66% |
| AWM Investment Company, Inc. | 6,015,000 | $23,338,200 | 3.36% |
| EAM Investors, LLC | 1,749,598 | $6,788,440 | 1.40% |
| Perceptive Advisors | 11,900,255 | $46,172,989 | 1.30% |
| EAM Global Investors LLC | 836,323 | $3,244,933 | 0.84% |
| Potomac Capital Management, Inc. | 120,000 | $466 | 0.54% |
| OBERWEIS ASSET MANAGEMENT INC/ | 536,900 | $2,083,172 | 0.44% |